ArticleCureus2025
Conservative Management of a Rare Gastrobronchial Fistula Following Minimally Invasive Esophagectomy: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A gastrobronchial fistula (GBF) is an uncommon condition in which an abnormal connection develops between the stomach and the lungs. It can occasionally arise as a complication following esophagectomy for esophageal adenocarcinoma. Management of GBF includes both surgical and nonsurgical approaches, depending on the patient's condition and comorbidities. Conservative management focuses on diversion to promote fistula closure; options include esophageal stents, fasting, nasogastric drainage, proton pump inhibitors, and jejunostomy feeds. Surgical options include resection of the fistula, anastomosis revision, and closure of the gastric conduit and bronchial aperture. We present a rare case of a 78-year-old male diagnosed with a GBF nearly two years after a minimally invasive distal esophagectomy for esophageal adenocarcinoma. Multiple diagnostic modalities, including endoscopy, CT, and contrast esophagram, were used to establish the diagnosis. The patient elected stent placement from the esophagus to the distal stomach due to poor functional status and was maintained on jejunostomy tube feeds. He was discharged in stable condition. This case highlights a conservative approach to treating GBF using a self-expanding stent (Endo-Flex GmbH, Voerde, Germany) and X-Tack (Apollo Endosurgery, Inc., Austin, TX, USA), an endoscopic suture device used to anchor the stent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.